Coronary interventions

Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold

EuroIntervention 2015;11:141-148 published online ahead of print May 2015. DOI: 10.4244/EIJY15M05_06

J. Ribamar Costa Jr
José De Ribamar Costa Jr1*, MD, PhD; Alexandre Abizaid1, MD, PhD; Antonio L. Bartorelli2, MD; Robert Whitbourn3, MD; Robert Jan van Geuns4, MD, PhD; Bernard Chevalier5, MD; Marcos Perin6, MD, PhD; Ashok Seth7, MD; Roberto Botelho8, MD, PhD; Patrick W. Serruys4, MD, PhD; on behalf of the ABSORB EXTEND Investigators
1. Instituto de Cardiologia Dante Pazzanese, São Paulo, Brazil; 2. Centro Cardiologico Monzino, IRCCS, University of Milan, Milan, Italy; 3. St Vincent’s Hospital, Fitzroy, Victoria, Australia; 4. Thoraxcenter, Erasmus University Medical Center, Rotterdam

Aims: We sought to determine the impact of post-dilation (PD) on clinical outcomes in a large cohort of patients treated only with the Absorb Bioresorbable Vascular Scaffold (BVS).

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

bioresorbable scaffoldcoronary artery diseasepercutaneous coronary interventionpost-dilation
Read next article
Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds

Latest news